These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 26802299

  • 1. Prevalence of the Factor XIII Val34Leu Polymorphism in Korean Patients with Deep Vein Thrombosis.
    Kim SD, Hwang JK, Park SC, Kim JI, Won YS, Yun SS, Moon IS, Park JS.
    Ann Vasc Surg; 2016 Apr; 32():57-64. PubMed ID: 26802299
    [Abstract] [Full Text] [Related]

  • 2. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
    Van Hylckama Vlieg A, Komanasin N, Ariëns RA, Poort SR, Grant PJ, Bertina RM, Rosendaal FR.
    Br J Haematol; 2002 Oct; 119(1):169-75. PubMed ID: 12358922
    [Abstract] [Full Text] [Related]

  • 3. Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.
    Weger M, Renner W, Stanger O, Schmut O, Deutschmann H, Wascher TC, Haas A.
    Stroke; 2001 Dec 01; 32(12):2759-61. PubMed ID: 11739969
    [Abstract] [Full Text] [Related]

  • 4. The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma.
    Shemirani AH, Haramura G, Bagoly Z, Muszbek L.
    Biochim Biophys Acta; 2006 Aug 01; 1764(8):1420-3. PubMed ID: 16920044
    [Abstract] [Full Text] [Related]

  • 5. The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
    Wells PS, Anderson JL, Rodger MA, Carson N, Grimwood RL, Doucette SP.
    Blood Coagul Fibrinolysis; 2006 Oct 01; 17(7):533-8. PubMed ID: 16988547
    [Abstract] [Full Text] [Related]

  • 6. Association of a common polymorphism in the factor XIII gene with venous thrombosis.
    Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ.
    Blood; 1999 Feb 01; 93(3):906-8. PubMed ID: 9920839
    [Abstract] [Full Text] [Related]

  • 7. Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome.
    Diz-Kucukkaya R, Hancer VS, Inanc M, Nalcaci M, Pekcelen Y.
    Lupus; 2004 Feb 01; 13(1):32-5. PubMed ID: 14870915
    [Abstract] [Full Text] [Related]

  • 8. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
    Kattula S, Bagoly Z, Tóth NK, Muszbek L, Wolberg AS.
    J Thromb Haemost; 2020 Apr 01; 18(4):885-894. PubMed ID: 31989767
    [Abstract] [Full Text] [Related]

  • 9. The association between factor XIII Val34Leu polymorphism and early myocardial infarction.
    Hancer VS, Diz-Kucukkaya R, Bilge AK, Ozben B, Oncul A, Ergen G, Nalcaci M.
    Circ J; 2006 Mar 01; 70(3):239-42. PubMed ID: 16501286
    [Abstract] [Full Text] [Related]

  • 10. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction.
    Elbaz A, Poirier O, Canaple S, Chédru F, Cambien F, Amarenco P.
    Blood; 2000 Jan 15; 95(2):586-91. PubMed ID: 10627467
    [Abstract] [Full Text] [Related]

  • 11. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
    Franco RF, Reitsma PH, Lourenço D, Maffei FH, Morelli V, Tavella MH, Araújo AG, Piccinato CE, Zago MA.
    Thromb Haemost; 1999 May 15; 81(5):676-9. PubMed ID: 10365735
    [Abstract] [Full Text] [Related]

  • 12. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G, Tàssies D, Espinosa G, Monteagudo J, Bové A, Plaza J, Cervera R, Reverter JC.
    Thromb Haemost; 2009 Feb 15; 101(2):312-6. PubMed ID: 19190815
    [Abstract] [Full Text] [Related]

  • 13. Factor XIII Val34Leu polymorphism in primary intracerebral haemorrhage.
    Corral J, Iniesta JA, González-Conejero R, Villalón M, Rivera J, Vicente V.
    Hematol J; 2000 Feb 15; 1(4):269-73. PubMed ID: 11920201
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D, Serino ML, Ongaro A, Tognazzo S, Moratelli S, Resca R, Moretti M, Scapoli GL.
    Am J Hematol; 2001 Jul 15; 67(3):183-8. PubMed ID: 11391716
    [Abstract] [Full Text] [Related]

  • 19. Association of Coagulation Factors VIII/XI/XIII Polymorphisms With Coagulation Factor Activities and Deep Vein Thrombosis After Artificial Joints Replacement.
    Su W, Lv M, Xu X, Li B, Liu HY, Ning B, Li Y.
    Am J Ther; 2016 Jul 15; 23(6):e1547-e1553. PubMed ID: 26934731
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.